Home Johnson & Johnson Invests $1 Billion to Expand ACUVUE Contact Lens Production in Jacksonville, Florida

Johnson & Johnson Invests $1 Billion to Expand ACUVUE Contact Lens Production in Jacksonville, Florida

Jun 16, 2026 16:20 CST Updated 16:20
Johnson & Johnson

Medical Device R&D and Manufacturer

图片
Device Home

Pioneer in Medical Device Media Coverage

Sharing Professional Medical Device Knowledge

Follow

Source:Home of Medical Devices,No reposting without authorization; reposting is permitted only after 24 hours.

2026Year6Month15Day,Johnson & Johnson, the Healthcare Technology GiantAnnounced, invested10USD 100 millionEquivalent to approximately RMB68100 million)to enhance its production capacity in FloridaThis investment is part of the company's plan to2029Years ago, total investment55part of a major plan to expand overall production capacity in the United States with hundreds of millions of dollars.


Image


01

Annual production capacity of 1.7 billion contact lenses

This investment will strengthen Johnson & Johnson's existing manufacturing operations in Jacksonville.will also support the construction of new distribution facilities, which are expected to be2028completed construction and commenced operations in the year.This InvestmentTranslateExpanding Johnson & Johnson’s local high-end manufacturing and packaging capabilities, primarily to meet the demands of itsACUVUE The Growing Demand for Branded Contact Lenses.


According to data provided by Johnson & Johnson, the company produces more than for U.S. users annually17100 million tabletsACUVUE Contact Lenses: In the company's financial report for the first quarter of this year, the total revenue from contact lenses in the United States region amounted to4.68hundred million US dollars, an increase of compared to the same period last year3.7%


Johnson & Johnson CEO Duane Q.Joaquin Duato “The investment further reinforces our long-held belief that advanced manufacturing in the United States is critical to delivering innovative, high-quality healthcare solutions to customers both domestically and internationally. By further upgrading our production operations in Jacksonville, complemented by next-generation manufacturing, packaging, and distribution capabilities, we are strengthening the resilience of the U.S. supply chain while helping more people see better and live healthier lives.”


Speaking of Johnson & Johnson’s investment in Jacksonville, combined with the annual impact Johnson & Johnson brings to Florida60hundred million dollars in economic impact. Jacksonville Mayor Donna Deegan stated, “Johnson & Johnson’s commitment demonstrates strong confidence in Jacksonville, our local workforce, and the future. This expansion will not only strengthen the region’s high-tech industrial landscape but also create quality jobs for the local community and bring long-term development opportunities.”


02

Related Background: $5.5 Billion Commitment to Production Expansion

This time10billion-dollar investment, and Johnson & Johnson in2025Year3announced in May55the commitment to expanding U.S. production, valued at hundreds of millions of dollars, is consistent with this approach,This plan will be launched, partly driven byGovernmentIssuedPharmaceuticalsDriven by industry incentive policies.


During its first-quarter earnings conference call this year, Johnson & Johnson revealed that2025By the end of the year, a total of approximately12billion USD to advance its U.S. production operations, accounting for the company's total commitment55approximately $100 million22%In addition to the current Jacksonville project, other significant manufacturing investments recently include:


Project
Amount
Location
Announcement Time
Cell Therapy Facility
$1 billion
Montgomery County, Pennsylvania
February 2026
Biologics Manufacturing Facility
$2 billion
Wilson, North Carolina
November 2025
Expansion of Contact Lens Production Capacity
$1 billion
Jacksonville, Florida
June 2026

Johnson & Johnson's latest production expansion,CoincidentallyThis aligns well with the policy window driven by the United States to reshore its pharmaceutical supply chain. MedTribune believes that although the contact lens business accounts for a small proportion of Johnson & Johnson’s overall revenue,3.7%The year-on-year growth indicates that there is still room for expansion in this market segment, invest10$100 million to expand production capacity, essentially a mid-to-long-term strategic move in capacity layout.





END
 


ShangBusiness Cooperation Email: qxzj@landianyiliao.com